immuron.com.au (IMRN) Value Adjusted for Debt and Cash
The biopharmaceutical business of Immuron Limited (IMRN) relies on the sale of over-the-counter gut protection products that provide high returns with low costs, while the Australian management scales the distribution of anti-diarrheal drugs through government defense contracts. This price trend chart shows that the enterprise value is 1.17. Demand in this niche is sustained by tourists and participants of overseas expeditions.
Immuron (IMRN) - metric breakdowns and financial figures
The stability of the bio-raw material base of Immuron Limited, which relies on Australian farms, forms the foundation of its production potential. The company's real market price is calculated as the sum of market capitalization and liabilities minus liquid assets. This metric determines the actual cost of a full business buyout. The dynamics of this indicator allow an investor to identify undervaluation or the risk of overpayment. The current trend reflects the market value of all operational capacities.